The vision of T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments based on live bacteria.
T3 Pharmaceuticals was acquired by Boehringer Ingelheim on 22 November 2023.
- http://www.t3pharma.com
- Send an email
- Dr. Simon J. Ittig